by In2Pharma | Jan 11, 2023 | News
The Netherlands Marketing authorization holders who want to temporarily supply a medicine in a different packaging in the event of a medicine shortage will need permission from the CBG from 1 January 2023. The CBG will take over this task from the Healthcare and Youth...
by In2Pharma | Dec 22, 2022 | News
Europe The European Commission had published an update of the Guidance document describing the food categories in Part E of Annex II to Regulation (EC) No 1333/2008 on Food Additives. In this new version the following changes are made: – update of Category 17,...
by In2Pharma | Dec 22, 2022 | News
Belgium Most important is the increase of hospitality that can be provided to healthcare professionals. The maximum amount for a lunch will be increased to 45€, for a dinner to 90€. A total maximum of 135€/day may be offered as hospitality to HCPs in the context of at...
by In2Pharma | Dec 15, 2022 | News
Luxembourg There has been an update on: New instructions for the preparation and submission of additional risk minimisation material (aRMM) for evaluation and approval in Luxembourg: update contact detail adverse event reportingupdate address to send the printed...
by In2Pharma | Dec 15, 2022 | News
Europe EMA’s safety committee, PRAC, has concluded its review of medicines containing pholcodine, which are used in adults and children to treat non-productive (dry) cough and, in combination with other active substances, for the treatment of symptoms of...
